RV
Reviva Pharmaceuticals Holdings, Inc.
RVPH · OTC
$0.50 +4.17% (+$0.02)
1M +0.31%
Market Cap $6.41M
P/E Ratio -
Div. Yield -
ROE 64.39%
Bulios Fair Price
$0.61
22.0% upside
Current Price
$0.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RVPH is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.00x
P/E N/A
EV/EBITDA N/A
Growth
30 /100
Declining Book val. growth 1.00%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 17.07%
ROE 64.39%
ROA 11.58%
Debt
69 /100
Low Debt/Equity 0.01x
Current ratio 3.56x
Int. coverage 0.00x
Stability
48 /100
Moderate Beta 0.50x
EPS volatility 42.89%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RVPH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Laxminarayan Bhat
Employees
14
Headquarters
Cupertino
Upcoming events
12 NOV
Earnings
Upcoming earnings report